Drug Evaluated as ‘Necessary for Reimbursement’ by Pharmaceutical Committee30-Day Negotiation Period Upon Ministry’s Directive
주식 : AstraZeneca has announced its decision to withdraw its diabetes treatment, ‘Farxiga, from the Korean market due to challenges with drug pri